KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 159 filers reported holding KITE PHARMA INC in Q2 2015. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,747,000 | +22.5% | 35,000 | -30.0% | 0.54% | -5.5% |
Q4 2016 | $2,242,000 | -19.7% | 50,000 | 0.0% | 0.57% | +24.8% |
Q3 2016 | $2,793,000 | +11.7% | 50,000 | 0.0% | 0.46% | -29.9% |
Q2 2016 | $2,500,000 | +8.9% | 50,000 | 0.0% | 0.65% | +30.3% |
Q1 2016 | $2,296,000 | -25.5% | 50,000 | 0.0% | 0.50% | +10.4% |
Q4 2015 | $3,081,000 | -2.9% | 50,000 | -12.2% | 0.45% | +11.4% |
Q3 2015 | $3,172,000 | -8.7% | 56,970 | 0.0% | 0.40% | +19.1% |
Q2 2015 | $3,473,000 | -8.7% | 56,970 | -13.6% | 0.34% | -14.1% |
Q1 2015 | $3,805,000 | -40.5% | 65,970 | -40.6% | 0.40% | -63.7% |
Q4 2014 | $6,400,000 | +230.4% | 110,970 | +63.3% | 1.09% | +356.1% |
Q3 2014 | $1,937,000 | – | 67,970 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |